clofibric acid has been researched along with Myositis in 2 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Myositis: Inflammation of a muscle or muscle tissue.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Myositis was significantly associated with statin monotherapy (RR 2." | 1.34 | Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population. ( Glanz, M; Hokanson, JE; McClure, DL; Murphy, JR; Valuck, RJ, 2007) |
| "Monotherapy for the treatment of dyslipidemias is commonly insufficient to achieve all lipid targets recommended by current guidelines." | 1.33 | [Drug combinations: statins and fibrates]. ( Xavier, HT, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xavier, HT | 1 |
| McClure, DL | 1 |
| Valuck, RJ | 1 |
| Glanz, M | 1 |
| Murphy, JR | 1 |
| Hokanson, JE | 1 |
2 other studies available for clofibric acid and Myositis
| Article | Year |
|---|---|
[Drug combinations: statins and fibrates].
Topics: Age Factors; Clofibric Acid; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Female; Ge | 2005 |
Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population.
Topics: Age Factors; Aged; Clofibric Acid; Cohort Studies; Confidence Intervals; Confounding Factors, Epidem | 2007 |